Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Hematology

Living with Hemophilia A: Joint Health & Daily Life

At a Glance

To live well with Hemophilia A and prevent permanent joint damage, maintain routine prophylactic treatment. Staying active builds protective muscle, but always avoid NSAIDs for pain and coordinate your care through a specialized Hemophilia Treatment Center.

Managing Hemophilia A is no longer just about survival; it is about thriving. With modern treatment, the focus has shifted toward achieving a “hemophilia-free state”—a level of protection where you can live without the constant fear of bleeding and the burden of frequent infusions [1][2].

Protecting Your Joints: Preventing Arthropathy

The greatest long-term risk in hemophilia is hemophilic arthropathy (joint damage). When a joint bleeds (hemarthrosis), the blood releases iron, which causes inflammation and gradually damages the cartilage [3][4].

  • The Vicious Cycle: One bleed can lead to synovial hypertrophy (thickening of the joint lining), which makes the joint more likely to bleed again [5].
  • The Solution: Prophylaxis is the “gold standard” for preventing this damage. By keeping factor levels high, you stop the bleeds before they start, arresting the cycle of joint destruction [6][7].

Safe Pain Management

If you experience joint or muscle pain, it is critical to manage it safely.

  • Avoid: You must completely avoid NSAIDs (like ibuprofen, aspirin, or naproxen). These medications inhibit platelets from working properly, which can significantly increase your bleeding risk and turn a minor injury into a severe bleed.
  • Safe Alternative: Acetaminophen is generally the safe and recommended over-the-counter pain medication for people with hemophilia, as it does not affect platelets. Always clear any pain medication with your hematologist first.

Your Home Base: The Hemophilia Treatment Center (HTC)

Success in hemophilia care depends on a multidisciplinary team. Research shows that people who receive care at a specialized Hemophilia Treatment Center (HTC) have better outcomes [8]. Your team typically includes:

  • Hematologist: Manages your factor levels and treatment plan.
  • Physical Therapist: Evaluates joint health using tools like the Hemophilia Joint Health Score (HJHS) [9].
  • Social Worker/Psychologist: Helps navigate the emotional toll, school plans (504 plans), and insurance challenges [10].
  • Orthopedist: Specializes in joint preservation and surgery if needed.

Physical Activity and Sports

Exercise is not just safe; it is essential. Strong muscles help protect joints from bleeding [11]. Current research indicates that sports participation does not inherently increase bleeding risk, provided you maintain adequate factor coverage [12].

Activity Level Examples Recommendations
Green Light Swimming, cycling, golf, walking, tennis Highly encouraged; excellent for muscle strength [11].
Yellow Light Basketball, soccer, baseball Safe for most if prophylaxis is timed correctly (infuse shortly before activity) [13].
Red Light Football, boxing, wrestling, rugby Generally discouraged due to high risk of head and internal bleeds.

The Psychological Journey and The First Year

Living with a chronic condition requires significant emotional resilience. In the first year following a diagnosis, expect to visit the clinic frequently as your team fine-tunes your dosing and teaches you or your child how to manage treatments. It is completely normal for parents to feel “caregiver burnout” or for adult patients to feel frustrated by treatment schedules.

  • Normalization: Over time, treatment becomes a routine part of life, rather than the defining feature of it. Modern therapies like emicizumab or gene therapy are designed to make hemophilia a smaller part of your life, reducing the mental energy spent on needles and monitoring [14][15].
  • Support: Lean on your HTC team for psychosocial support. They can connect you with patient advocacy groups where you can meet others who understand the daily reality of Hemophilia A.

By staying proactive with prophylaxis and maintaining a strong relationship with your HTC, you can focus on your goals and activities rather than just managing a diagnosis [10][16].

Common questions in this guide

Why is joint health so important for people with Hemophilia A?
Joint bleeds release iron that causes inflammation and gradually damages cartilage, leading to a condition called hemophilic arthropathy. Maintaining your prophylactic treatment helps stop these bleeds before they start, which protects your long-term joint health.
What pain medications are safe to take for joint pain with Hemophilia A?
Acetaminophen is generally the recommended over-the-counter pain medication because it does not interfere with blood clotting. You must completely avoid NSAIDs like ibuprofen, aspirin, and naproxen, as they stop platelets from working properly and significantly increase your bleeding risk.
Can I safely play sports if I have Hemophilia A?
Yes, regular exercise is essential because strong muscles help protect your joints from bleeding. Activities like swimming and cycling are highly encouraged, though contact sports should be avoided. Always consult your hematologist to ensure you have proper factor coverage before playing sports.
What is a Hemophilia Treatment Center (HTC)?
An HTC is a specialized clinic that provides comprehensive, multidisciplinary care for bleeding disorders. Your team will include a hematologist, physical therapist, orthopedist, and social worker who work together to manage your factor levels, joint health, and emotional well-being.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Can we perform a musculoskeletal ultrasound or MRI to look for 'subclinical' (silent) joint damage?
  2. 2.Based on my current prophylaxis, which sports or physical activities are 'green light' vs. 'yellow light'?
  3. 3.How often should we meet with the HTC physical therapist to monitor joint health (HJHS scores)?
  4. 4.What is our plan for managing sports participation—do we need to time my infusion for just before activity?
  5. 5.What mental health resources does the HTC offer for managing the stress of chronic infusions?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (16)
  1. 1

    Contemporary approaches to treat people with hemophilia: what's new and what's not?

    Valentino LA, Santaella ME, Carlson SA, Recht M

    Research and practice in thrombosis and haemostasis 2025; (9(1)):102696 doi:10.1016/j.rpth.2025.102696.

    PMID: 40084158
  2. 2

    Etranacogene dezaparvovec for the treatment of adult patients with severe and moderately severe hemophilia B.

    Castaman G, Coppens M, Pipe SW

    Expert review of hematology 2023; (16(12)):919-932 doi:10.1080/17474086.2023.2276206.

    PMID: 37882214
  3. 3

    The good, the bad and the ugly of pain in haemophilia: Recent evidence on the epidemiology, molecular mechanisms and knowledge gaps preventing optimal treatment.

    Benemei S, Mattia C, Di Minno MND

    Haemophilia : the official journal of the World Federation of Hemophilia 2024; (30(3)):589-597 doi:10.1111/hae.15002.

    PMID: 38545868
  4. 4

    Ferroptosis: a new target for iron overload-induced hemophilic arthropathy synovitis.

    Han Z, Zheng L, Luo D, et al.

    Annals of hematology 2023; (102(5)):1229-1237 doi:10.1007/s00277-023-05190-w.

    PMID: 36951967
  5. 5

    Pathophysiology of hemophilic arthropathy and potential targets for therapy.

    Pulles AE, Mastbergen SC, Schutgens RE, et al.

    Pharmacological research 2017; (115()):192-199 doi:10.1016/j.phrs.2016.11.032.

    PMID: 27890816
  6. 6

    Timely and large dose of clotting factor IX provides better joint wound healing after hemarthrosis in hemophilia B mice.

    He P, Zhang F, Zhong C, et al.

    International journal of hematology 2019; (110(1)):59-68 doi:10.1007/s12185-019-02639-5.

    PMID: 31006077
  7. 7

    Primary prophylaxis was associated with lower arthropathy in Colombian men with haemophilia B: A longitudinal analysis (2015-2019).

    Hernández Vargas JA, Linares A, Solano MH, et al.

    Haemophilia : the official journal of the World Federation of Hemophilia 2020; (26(6)):e282-e290 doi:10.1111/hae.14136.

    PMID: 32892455
  8. 8

    Hemophilic arthropathy: Current knowledge and future perspectives.

    Gualtierotti R, Solimeno LP, Peyvandi F

    Journal of thrombosis and haemostasis : JTH 2021; (19(9)):2112-2121 doi:10.1111/jth.15444.

    PMID: 34197690
  9. 9

    Cardiac surgery in patients with Hemophilia:is it safe?

    Shalabi A, Kachel E, Kogan A, et al.

    Journal of cardiothoracic surgery 2020; (15(1)):76 doi:10.1186/s13019-020-01123-0.

    PMID: 32384896
  10. 10

    Current challenges in the management of hemophilia.

    Bauer KA

    The American journal of managed care 2015; (21(6 Suppl)):S112-22.

    PMID: 26168206
  11. 11

    Moderate- to vigorous-intensity physical activities for hemophilia A patients during low-dose pharmacokinetic-guided extended half-life factor VIII prophylaxis.

    Srichumpuang C, Rakmanotham A, Moonla C, Sosothikul D

    Orphanet journal of rare diseases 2024; (19(1)):135 doi:10.1186/s13023-024-03092-2.

    PMID: 38532451
  12. 12

    Association between Sports Participation, Factor VIII Levels and Bleeding in Hemophilia A.

    Bukkems LH, Versloot O, Cnossen MH, et al.

    Thrombosis and haemostasis 2023; (123(3)):317-325 doi:10.1055/a-1983-0594.

    PMID: 36402130
  13. 13

    Impact of mild to severe hemophilia on engagement in recreational activities by US men, women, and children with hemophilia B: The Bridging Hemophilia B Experiences, Results and Opportunities into Solutions (B-HERO-S) study.

    Baumann K, Hernandez G, Witkop M, et al.

    European journal of haematology 2017; (98 Suppl 86()):25-34 doi:10.1111/ejh.12852.

    PMID: 28319336
  14. 14

    Gene Therapy of Haemophilia: Current Status and Future Directions.

    Miesbach W

    Hamostaseologie 2026; (46(1)):10-16 doi:10.1055/a-2751-7625.

    PMID: 41702383
  15. 15

    [Gene therapy of Hemophilia: Recommendations from the German, Austrian, and Swiss Society for Thrombosis and Haemostasis Research (GTH)].

    Miesbach W, Oldenburg J, Klamroth R, et al.

    Hamostaseologie 2023; (43(3)):196-207 doi:10.1055/a-1957-4477.

    PMID: 36516966
  16. 16

    An Observational Study of Glycopegylated Extended Half-Life Factor Prophylaxis in Hemophilia A and B in a Tertiary Care Center in India.

    Bhatt P, Patel H

    Cureus 2025; (17(2)):e79815 doi:10.7759/cureus.79815.

    PMID: 40161079

This page provides general information on living with Hemophilia A and protecting joint health. Always consult your hematologist and Hemophilia Treatment Center team before starting new physical activities or changing your pain management routine.

Get notified when new evidence is published on Hemophilia A.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.